Merck KGaA Financially Commits $322 Million Toward Research Center


The complex will research solutions for manufacturing antibodies, mRNA applications, and more.

Image Credit: Merck KGaA

Image Credit: Merck KGaA

Merck KGaA, a science and technology company, will be financially committing more than $322 million (€300 million) into a brand-new, 18,000 square-foot research center at its global headquarters in Darmstadt, Germany.

Known as the “Advanced Research Center,” the company’s life science business branch plans on exploring solutions surrounding mRNA applications and manufacturing antibodies, along with products needed required for biotechnological production. By the start of 2027, it is anticipated to provide enough space for around 550 employees.

The new center only represents a component of a larger investment program surrounding the Darmstadt plant; by 2025, Merck KGaA will be investing around a total of $1.6 billion (€1.5 billion).

“Investments such as those made by Merck KGaA, Darmstadt, Germany, here at its headquarters in Darmstadt make tremendous economic, medical and scientific sense,” said Federal Chancellor Olaf Scholz. “They are a tribute to Germany as a leading pharmaceutical, industrial, and research location, and reflect the strength of the life sciences. All of this proves that we are on the right track with the changes that we have made with a view to offering the pharmaceutical and biotech industry better conditions. The German government will continue to tread this path with all due resolve.”

The financial commitment also takes a step toward solidifying the company’s reputation in the drug development space.

“With this strategic investment, we are strengthening our company’s leading position in key technologies for the development and manufacture of novel medicines,” commented Belén Garijo, chair of the executive board and CEO of Merck KGaA, Darmstadt, Germany. “As a leading provider of life science technologies, we continue to invest in research and development ‘Made in Germany.’ In doing so, we are enabling scientific progress for the benefit of millions of patients and customers around the world.”


Merck KGaA, Darmstadt, Germany, Invests More Than € 300 Million in New Life Science Research Center. April 25, 2024. Merck KGaA. Accessed April 30, 2024.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.